REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

AQR CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001167557)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 78,988 Value ($000) $240 Avg Close Range
Q3 2024
Shares 99,187 Value ($000) $515 Avg Close Range
Q2 2024
Shares 201,080 Value ($000) $517 Avg Close Range
Q1 2024
Shares 30,120 Value ($000) $148 Avg Close Range
Q2 2023
Shares 13,483 Value ($000) $341 Avg Close Range
Q1 2023
Shares 14,200 Value ($000) $457 Avg Close Range
Q3 2021
Shares 9,691 Value ($000) $270 Avg Close Range
Q2 2021
Shares 9,691 Value ($000) $287 Avg Close Range
Q1 2021
Shares 16,208 Value ($000) $453 Avg Close Range
Q4 2020
Shares 17,594 Value ($000) $499 Avg Close Range
Q3 2020
Shares 20,141 Value ($000) $506 Avg Close Range
Q2 2020
Shares 13,303 Value ($000) $325 Avg Close Range
Q3 2018
Shares 8,086 Value ($000) $201 Avg Close Range
Q2 2018
Shares 13,249 Value ($000) $364 Avg Close Range
Q1 2018
Shares 13,210 Value ($000) $407 Avg Close Range
Q4 2017
Shares 12,854 Value ($000) $460 Avg Close Range
Q3 2017
Shares 10,391 Value ($000) $286 Avg Close Range
Q2 2016
Shares 12,073 Value ($000) $164 Avg Close Range
Q1 2016
Shares 15,187 Value ($000) $265 Avg Close Range
Q4 2015
Shares 12,521 Value ($000) $428 Avg Close Range